The p21 cip1/waf1 cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells
- 10 November 2000
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 161 (1) , 17-26
- https://doi.org/10.1016/s0304-3835(00)00586-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ovarian carcinoma cells are effectively transfected by polyethylenimine (PEI) derivativesCancer Gene Therapy, 2000
- p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cellsOncogene, 1998
- Analysis of the Rb Gene and Cyclin-Dependent Kinase 4 Inhibitor Genes (p16INK4and p15INK4B) in Human Ovarian Carcinoma Cell LinesExperimental Cell Research, 1997
- Role of p21Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cellsOncogene, 1997
- Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21Nature, 1996
- Expression of p21WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinomaInternational Journal of Cancer, 1995
- Cisplatin Resistance in a Murine Leukemia Cell Line Is Associated with a Defective Apoptotic ProcessExperimental Cell Research, 1995
- The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNANature, 1994
- High-Efficiency Transfection of Primary Human Keratinocytes with Positively Charged Lipopolyamine: DNA ComplexesJournal of Investigative Dermatology, 1994
- p53 Mutations in Human CancersScience, 1991